The functional role of IgE to staphylococcus aureus enterotoxins in severe asthma Source: International Congress 2019 – Understanding the mechanisms underlying airway diseases Year: 2019
The impact of sensitization to Staphylococcus aureus–derived enterotoxins on allergic and respiratory disorders Source: Virtual Congress 2020 – Mechanism or pathways of chronic lung diseases Year: 2020
Development of an innovative, Staphylococcus aureus enterotoxin B (SEB)-aided rat model of atopic asthma Source: International Congress 2017 – Animal models of asthma and allergies Year: 2017
Detection of alpha-hemolysin in Staphylococcus aureus derived respiratory strains: correlation with microbiological and clinical variables Source: International Congress 2017 – Respiratory infections in critically ill and immuno-depressed patientes Year: 2017
Mechanisms of acquisition of resistance in Staphylococcus aureus Source: Annual Congress 2006 - Methicillin resistant Staphylococcus aureus (MRSA): a real hospital-based pathogen? Year: 2006
What is MRSA? Source: Eur Respir J 2009; 34: 1190-1196 Year: 2009
Nasal polyposis and asthma: a mechanistic paradigm focusing on Staphylococcus aureus Source: Eur Respir Monogr 2017; 76: 122-137 Year: 2017
Predictive factors for methicillin-resistant Staphylococcus aureus (MRSA) infection in a MRSA screening protocol. Source: International Congress 2018 – Difficult-to-treat respiratory infections Year: 2018
Moulds and Staphylococcus aureus enterotoxins are relevant allergens to affect Type 2 inflammation and clinical outcomes in chronic rhinosinusitis patients Source: ERJ Open Res, 6 (4) 00265-2020; 10.1183/23120541.00265-2020 Year: 2020
Prevalence and impact on FEV1 decline of methicillin-resistant Staphylococcus aureus infection in patients with cystic fibrosis Source: Annual Congress 2011 - Cystic fibrosis: new basic, clinical and bacteriological knowledge Year: 2011
Staphylococcus aureus in children with tracheostomy : Correlation with clinical outcomes Source: International Congress 2019 – Paediatric respiratory infections around the world: Tuberculosis, pneumonia and others Year: 2019
Human airway epithelial cell response to Pseudomonas aeruginosa virulence factors preceded or not by Staphylococcus aureus Source: Eur Respir J 2006; 28: Suppl. 50, 191s Year: 2006
An experimental model of pneumonia induced by methicillin-resistant Staphylococcus aureus in ventilated piglets Source: Eur Respir J 2010; 36: 901-906 Year: 2010
The effect of polyvalent mechanical bacterial lysate on the reduction of nasal Staphylococcus aureus carriage in children with pollen allergic rhinitis Source: International Congress 2019 – Asthma biomarkers, diagnostics and risk factors Year: 2019
Community-associated methicillin-resistant staphylococcus aureus (CA-MRSA) as a cause of hospital-acquired pneumonia (HAP) Source: Eur Respir J 2007; 30: Suppl. 51, 410s Year: 2007
Community-acquired pneumonia due to S. aureus Source: Annual Congress 2011 - Aetiology, diagnosis and outcomes in community-acquired pneumonia Year: 2011
Staphlococcus aureus : susceptibility to antibacterial drugs and rate of MRSASource: Eur Respir J 2006; 28: Suppl. 50, 788s Year: 2006
Clinical outcomes of patients with hospital-acquired pneumonia due to community-associated methicillin resistant staphylococcus aureus (CA-MRSA) Source: Eur Respir J 2007; 30: Suppl. 51, 407s Year: 2007
A rising and alarming threat of Staphylococcus aureus Bacteremia in under 5 children Source: International Congress 2019 – Paediatric respiratory infections around the world: Tuberculosis, pneumonia and others Year: 2019